DE69927306D1 - Antibakterielle Verbindungen - Google Patents

Antibakterielle Verbindungen

Info

Publication number
DE69927306D1
DE69927306D1 DE69927306T DE69927306T DE69927306D1 DE 69927306 D1 DE69927306 D1 DE 69927306D1 DE 69927306 T DE69927306 T DE 69927306T DE 69927306 T DE69927306 T DE 69927306T DE 69927306 D1 DE69927306 D1 DE 69927306D1
Authority
DE
Germany
Prior art keywords
compounds
antibacterial compounds
xvi
xiv
xiii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69927306T
Other languages
English (en)
Other versions
DE69927306T2 (de
Inventor
Inukai Masatoshi
Kaneko Masakatsu
Takatsu Toshio
Hotoda Hitoshi
Arai Masatoshi
Miyakoshi Shunichi
Kizuka Masaaki
Ogawa Yasumasa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sequella Inc
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of DE69927306D1 publication Critical patent/DE69927306D1/de
Publication of DE69927306T2 publication Critical patent/DE69927306T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/167—Heterorings having sulfur atoms as ring heteroatoms, e.g. vitamin B1, thiamine nucleus and open chain analogs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DE69927306T 1998-07-09 1999-07-09 Antibakterielle Verbindungen Expired - Lifetime DE69927306T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP19428598 1998-07-09
JP19428598 1998-07-09
JP26944598 1998-09-24
JP26944598 1998-09-24

Publications (2)

Publication Number Publication Date
DE69927306D1 true DE69927306D1 (de) 2005-10-20
DE69927306T2 DE69927306T2 (de) 2006-07-06

Family

ID=26508414

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69927306T Expired - Lifetime DE69927306T2 (de) 1998-07-09 1999-07-09 Antibakterielle Verbindungen
DE69935513T Expired - Lifetime DE69935513T2 (de) 1998-07-09 1999-07-09 Antibakterielle verbindungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69935513T Expired - Lifetime DE69935513T2 (de) 1998-07-09 1999-07-09 Antibakterielle verbindungen

Country Status (23)

Country Link
US (2) US6472384B1 (de)
EP (3) EP1095947B1 (de)
KR (2) KR100622889B1 (de)
CN (1) CN1181087C (de)
AT (2) ATE304548T1 (de)
AU (1) AU751470B2 (de)
BR (1) BR9911965A (de)
CA (1) CA2337225C (de)
DE (2) DE69927306T2 (de)
DK (2) DK1095947T3 (de)
ES (2) ES2284260T3 (de)
HK (2) HK1053063A1 (de)
HU (1) HUP0103711A3 (de)
ID (1) ID27955A (de)
IL (3) IL140731A0 (de)
NO (1) NO322083B1 (de)
NZ (1) NZ509233A (de)
PL (1) PL200426B1 (de)
PT (1) PT1095947E (de)
RU (1) RU2209210C2 (de)
TR (1) TR200100059T2 (de)
WO (1) WO2000002892A1 (de)
ZA (1) ZA200100200B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI245047B (en) 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives
WO2002024491A1 (de) 2000-09-25 2002-03-28 Volkswagen Ag Airbagvorrichtung und betriebsverfahren dafür
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
CN101404986B (zh) * 2002-05-17 2011-09-28 赛奎拉公司 用于诊断和治疗感染性疾病的组合物和制药方法
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
EP1670314A4 (de) * 2003-09-05 2009-02-25 Sequella Inc Verfahren und zusammensetzungen enthaltend diamine als neue therapeutika für tuberkulose
WO2006025920A2 (en) * 2004-06-19 2006-03-09 Human Biomolecular Research Institute Modulators of central nervous system neurotransmitters
US20090068325A1 (en) * 2007-09-10 2009-03-12 Gil Depicciotto Method of treatment of fresh produce
WO2009136965A1 (en) * 2008-05-06 2009-11-12 Sequella, Inc. Compositions and methods comprising capuramycin analogues

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60259190A (ja) * 1984-06-06 1985-12-21 Kanto Ishi Pharma Co Ltd 新抗生物質カプラマイシン及びその製造法
US5034381A (en) * 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
JPH05148293A (ja) * 1991-11-28 1993-06-15 Mect Corp 新規カプラマイシン誘導体およびその製造方法
GB9307043D0 (en) 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
TWI245047B (en) * 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives

Also Published As

Publication number Publication date
CN1317008A (zh) 2001-10-10
US20030069204A1 (en) 2003-04-10
NO20010105L (no) 2001-03-08
CA2337225C (en) 2009-05-26
KR100622889B1 (ko) 2006-09-12
IL140731A0 (en) 2002-02-10
ATE356825T1 (de) 2007-04-15
ZA200100200B (en) 2002-06-26
NZ509233A (en) 2003-05-30
KR100729196B1 (ko) 2007-06-19
DE69927306T2 (de) 2006-07-06
ATE304548T1 (de) 2005-09-15
WO2000002892A1 (en) 2000-01-20
CA2337225A1 (en) 2000-01-20
NO322083B1 (no) 2006-08-14
HK1053127A1 (en) 2003-10-10
AU751470B2 (en) 2002-08-15
RU2209210C2 (ru) 2003-07-27
HUP0103711A3 (en) 2003-11-28
DK1095947T3 (da) 2007-07-16
EP1095947A4 (de) 2002-01-16
BR9911965A (pt) 2001-05-29
KR20060011919A (ko) 2006-02-03
US6472384B1 (en) 2002-10-29
AU4650599A (en) 2000-02-01
PL200426B1 (pl) 2009-01-30
EP1319666A1 (de) 2003-06-18
EP1319666B1 (de) 2005-09-14
IL140731A (en) 2008-06-05
ES2284260T3 (es) 2007-11-01
ES2248654T3 (es) 2006-03-16
DE69935513T2 (de) 2007-11-29
HUP0103711A2 (hu) 2002-02-28
KR20010083101A (ko) 2001-08-31
EP1095947B1 (de) 2007-03-14
EP1319406A1 (de) 2003-06-18
HK1053127B (zh) 2005-12-30
IL187551A0 (en) 2008-03-20
EP1095947A1 (de) 2001-05-02
TR200100059T2 (tr) 2001-05-21
DE69935513D1 (de) 2007-04-26
US6844173B2 (en) 2005-01-18
HK1053063A1 (zh) 2003-10-10
PL345403A1 (en) 2001-12-17
NO20010105D0 (no) 2001-01-08
PT1095947E (pt) 2007-06-20
ID27955A (id) 2001-05-03
CN1181087C (zh) 2004-12-22
IL187551A (en) 2009-12-24
DK1319666T3 (da) 2005-12-05

Similar Documents

Publication Publication Date Title
IL187551A0 (en) Antimicrobial capuramycin derivatives and pharmaceutical compositions containing the same
GEP20063831B (en) Substituted bicyclic derivatives for treatment of abnormal cell growth
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
GEP20094834B (en) Macrolides, pharmaceutical compositions containing them and their use for treatment of bacterial infections
MX9803650A (es) Agentes antimicrobianos de benzoxazina.
EG25017A (en) N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials.
NZ506058A (en) Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof
NO951198L (no) Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
PT825186E (pt) Derivados de 2-aminobenzazepina e sua utilizacao para o tratamento da imunossupressao
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
MX9708611A (es) Compuestos de dialquiltiacumicina.
ES2115424T3 (es) Derivados prolin-amidicos basicos de los antibioticos ge 2270 y similares a ge 2270.
MD1788G2 (ro) Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
WO2002018353A3 (en) Oxazolidinone chemotherapeutic agents
FR2412564A1 (fr) Nouvelles 2' -n-acyl- et alkyl-6' -n-alkyl- et 6', 6' -di-n-alkyl-fortimicines a et b, utiles notamment comme antibiotiques
GR3025607T3 (en) A novel antibiotic, Deoxymulundocandin, a process for its production and its use as medicament
GEP20033144B (en) Hygromycin A Derivatives as Antibacterial Agents
ATE390490T1 (de) Antibiotika-ge-81112-faktoren a, b, b1, pharmazeutisch unbedenkliche salze und zusammensetzungen sowie verwendungen davon
MD1105C2 (ro) N-(5-Nitro-2-furfuriliden)-4-aminobenzensulfamide, care manifestă activitate antimicrobiană
ECSP993176A (es) Nuevos compuestos y composiciones antibacterianas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SEQUELLA, INC., ROCKVILLE, MD., US

8328 Change in the person/name/address of the agent

Representative=s name: SERWE, K., DIPL.-ING., PAT.-ANW., 54290 TRIER

8328 Change in the person/name/address of the agent

Representative=s name: MOSELPATENT TRIERPATENT, 54290 TRIER

8328 Change in the person/name/address of the agent

Representative=s name: PATENTANWAELTE SERWE & DR. WAGNER, 54290 TRIER